The person, whose identity has not been revealed, may have been exposed to the virus in Democratic Republic of Congo and is now at the University of Nebraska Medical Center.

The study will examine the efficacy of four drugs—an antiviral and three monoclonal antibodies—that are already being used to treat patients in Democratic Republic of Congo.

As cases ramp up in Democratic Republic of Congo, the government has banned housing Ebola victims and promises police escorts for health workers at burials.

An accomplished infectious disease scientist, Meyers spent the 1960s treating and studying the condition in central Africa.

The number of cases in Democratic Republic of Congo’s latest outbreak of the virus has now surpassed 100.  

The monoclonal antibody, known as mAb114, is likely to be used in the current Ebola outbreak in DRC.

In response to a new outbreak, health workers will start administering vaccines again soon.

Four of six samples from the North Kivu province have tested positive for the virus.

No new cases have been reported since June 2, the World Health Organizations reports.